CBIO
#2804
Crescent Biopharma, Inc. - Common Stock
14.4 6 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.02%
Variación mensual
-25.85%
Variación en los últimos 6 meses
-20.15%
Cambio anual
+42.74%
Cierres anteriores
14.9 1
Open
14.7 9
Mínimo
14.3 2
Máximo
15.0 9
Financials
- Market Capitalization 537.1 M
- Employee 44
- Founded 2024
- CEO N/A
- Website www.crescentbiopharma.com
- Headquarter Cayman Islands
- FIGI N/A
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
1.75
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2130 |  MAZE Maze Therapeutics, Inc. - Common Stock | 27.70 USD | +2.18% | +4.33% | +11.24% | -38.49% | 1.54 B USD | ||
| 2166 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 30.15 USD | -1.63% | -8.41% | -31.94% | +15.12% | 1.45 B USD | ||
| 3016 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 7.26 USD | -2.81% | -3.97% | -18.88% | -57.42% | 393.24 M USD | ||
| 3364 |  QTTB Q32 Bio Inc. - Common Stock | 8.74 USD | +4.80% | +5.05% | -20.33% | +122.96% | 260.19 M USD |